Financial statements Allergopharma-Nexter

Balance sheet of Allergopharma-Nexter

Company age:
Age:
24 y. 10 d.
Share capital:
Share capital:
4 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of ALLERGOPHARMA-NEXTER

Year
2019
2020
2021
2022
2023
Total assets 3 399 689,76 3 786 760,60 3 587 527,92 4 056 646,35 2 672 427,49
A. Fixed assets 31 977,51 688 843,12 653 448,07 625 751,83 606 927,28
B. Current assets 3 367 712,25 3 097 917,48 2 934 079,85 3 417 954,88 2 065 500,21
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - 12 939,64 0,00
Total liabilities 3 399 689,76 3 786 760,60 3 587 527,92 4 056 646,35 2 672 427,49
A. Equity 3 184 441,22 3 347 318,31 3 558 886,33 3 954 591,46 2 625 251,13
B. Liabilities and provisions for liabilities 215 248,54 439 442,29 28 641,59 102 054,89 47 176,36
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 215 248,54 439 442,29 28 641,59 102 054,89 47 176,36
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.